Alliance for Cancer Gene Therapy
@ACGTFoundation
ACGT funds innovative scientists working to harness the power of cell and gene therapy to transform how cancer is treated and to drive momentum toward a cure.
Cell and gene therapies are helping cancer patients become cancer survivors. Read about some of these survivor stories on ACGT’s website: acgtfoundation.org/for-patients/p… #NationalCancerSurvivorsMonth
Congratulations to ACGT Board member Bruce Levine, and ACGT SAC members, Carl June, Michel Sadelain, and Isabelle Riviere for receiving the 2025 Richard N. Merkin Prize in Biomedical Technology for their roles in developing CAR T cell therapy! Read more: tinyurl.com/y65cuk9e
Recently, our director Dr. Sanaz Memarzadeh was a panelist at the Alliance for Cancer Gene Therapy @ACGTFoundation Summit. She discussed the challenges our lab & others face in developing gene therapies for Women’s Cancer as well as the instrumental progress that has been made.
Philip Greenberg, MD recently received a $500,000 grant co-funded by ACGT and @TheMarkFdn, supporting his research into inserting genes into T cells that can coordinate a response against tumor cells. Read more about Dr. Greenberg’s research here: tinyurl.com/5e9nx4de
This month for National Cancer Survivors Month, ACGT recognizes brave cancer patients and survivors who have undergone or are undergoing cell and gene therapy. Now, we want to help you tell your story. Please email David Statman at [email protected].
Supporting #CancerResearch & #ClinicalTrial funding W/ @ACGTFoundation with @SAA_Inc in Stamford CT. #MucosalMelanomaSurvivor #yourTILspeaker #TILtalks #CGT 🫳🎤
The ACGT – Edward Netter Memorial Investigator Award in Cell and Gene Therapy Research for Pancreatic Cancer has been awarded to a collaboration between Ben Z. Stanger, MD, PhD and Carl June, MD. Read more: acgtfoundation.org/news/alliance-…
NG34C, A Novel Oncolytic Virus Expressing Truncated GADD34 Gene for Glioblastoma “What makes funding from ACGT impactful is it fills a critical gap between the initial scientific discovery and running the exciting clinical trials. This in-between phase is crucial to advancing…
Scientists, There’s only one day left to submit a pre-application Letter of Intent for our 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research and Breast Cancer. Visit the ACGT website for full details: acgtfoundation.org/groundbreaking…
ALERT: ACGT has two open Requests for Applications for cancer cell and gene therapy research with LOIs due next week! Our focus this year is on women's cancers - learn more on our website: acgtfoundation.org/groundbreaking…
ACGT is now accepting applications for the 2025 Investigator Awards in Cell and Gene Therapy for Gynecological Research, as well as in Breast Cancer. The Letter of Intent deadline is May 16. Visit our website for more details: tinyurl.com/2d75sa2v
If you, or someone you know, has received cell and gene therapy for cancer and is in remission please share your experience with us. Survivor stories can inspire & empower others to learn more about cell and gene therapy. Please email David Statman at [email protected]
Last month, ACGT held its annual scientific summit – ACGT Summit 2025 – an invitation-only gathering bringing together top scientists in cancer cell and gene therapy. Read more about Summit 2025: acgtfoundation.org/news/acgt-summ…
Sign up today to receive ACGT’s monthly e-newsletter, highlighting the latest developments in cell and gene therapy for cancer: acgtfoundation.org/who-we-are/con…
New CAR T-Cell Therapy Approved for Leukemia - The FDA has approved AUCATZYL® (obecabtagene autoleucel – obe-cel) for the treatment of adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). autolus.gcs-web.com/news-releases/…
If you are attending @SITCcancer #SITC2024 but missed today's TIL Symposium, join ACGT on Friday and hear from Shari Pilon Thomas @MoffittNews and @GeorgeCoukos on the future of TIL therapy! Registration link is below - a few seats left so don't wait! acgt.givevirtuous.org/Event/acgt-sit…
El Rey recibe al ganador de la IV edición del “Abarca Prize”, el Dr. Carl H. June, profesor de la cátedra Richard W. Vague de Inmunoterapia en @PennMedicine y director del Instituto Parker de Inmunoterapia del Cáncer. ➡️casareal.es/ES/Actividades…
Alliance for Cancer Gene Therapy is holding a lunch symposium during the @sitcancer Annual Meeting on Friday 8th featuring speakers Drs. Crystal Mackall, Shari Pilon-Thomas and George Coukos. Registration is almost full but here's the link! acgt.givevirtuous.org/Event/acgt-sit… #SITC2024
If you are attending @sitcancer annual meeting, Alliance for Cancer Gene Therapy symposium with DR. Crystal Mackall and Dr. Shari Pilon-Thomas is on Friday November 8, 11:30-1:30 Registration is open but space is limited - link below: acgt.givevirtuous.org/Event/acgt-sit…
Elated that 10 years into the founding of the Delgoffe Lab, I've been officially promoted to Professor of Immunology at @PittTweet @PittHealthSci @UPMCHillmanCC! It has been a fun and exciting journey, that could not occurred without my incredible colleagues and trainees. Onward!